Fig. 5
From: Decreased PECAM-1 May be a potential pathological factor for vascular injury in T2DM patients
Fostamatinib can be used as a regulatory drug for PECAM-1.
Fig. 5 | Scientific Reports
From: Decreased PECAM-1 May be a potential pathological factor for vascular injury in T2DM patients
Fostamatinib can be used as a regulatory drug for PECAM-1.
